Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer

20260 citationsJournal Articlegold Open Access

Authors

NCT03164993, May 24<sup>th</sup> 2017; https://clinicaltrials.gov/ct2/show/record/NCT03164993.

Good health and well-being

Published in: The Breast

Volume 86, pp. 104704-104704

Field-Weighted Citation Impact: 0.00